| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6136347 | BAYER HLTHCARE | Flavor-masked pharmaceutical compositions |
Jan, 2013
(11 years ago) | |
|
US6136347 (Pediatric) | BAYER HLTHCARE | Flavor-masked pharmaceutical compositions |
Jul, 2013
(10 years ago) | |
| US5695784 | BAYER HLTHCARE | Flavor-masked pharmaceutical compositions |
Dec, 2014
(9 years ago) | |
|
US5695784 (Pediatric) | BAYER HLTHCARE | Flavor-masked pharmaceutical compositions |
Jun, 2015
(8 years ago) | |
Cipro is owned by Bayer Hlthcare.
Cipro contains Ciprofloxacin.
Cipro has a total of 4 drug patents out of which 4 drug patents have expired.
Expired drug patents of Cipro are:
- US6136347
- US6136347*PED
- US5695784
- US5695784*PED
Cipro was authorised for market use on 26 September, 1997.
Cipro is available in for suspension;oral dosage forms.
Cipro can be used as use of approved formulations to treat all approved disease indications.
The generics of Cipro are possible to be released after 09 June, 2015.
Drugs and Companies using CIPROFLOXACIN ingredient
Market Authorisation Date: 26 September, 1997
Treatment: Use of approved formulations to treat all approved disease indications
Dosage: FOR SUSPENSION;ORAL
How can I launch a generic of CIPRO before it's drug patent expiration?
More Information on Dosage
CIPRO family patents
